Discussion Forums > Working Towards a Cure
Bluebird Bio Releases Data on Current Gene Therapy Trials
Sharmin:
The recent news regarding Bluebird Bio's trials has been very positive for Beta + but not as great for Beta 0s. All patients have experienced improvement but 2 of the beta 0s have required one transfusion each and one is still dependent. I wonder however if more time is required to see the benefits for these patients. Beta 0s require a greater level of expression than Beta +. I'm glad there is improvement in all of the patients - I hope the team continues to fine tune the treatment until everyone can be cured. We are closer than we have ever been.
As an aside, I personally believe SKs vectors with Bluebird's preparation and diligence would be superior. Hopefully we will see carefully planned trials from SK soon.
Canadian_Family:
Thank you for sharing. I echo your comments on SK as being superior.
After so many years of wait, no one wants a cure with side effects of treatment impacting the quality of life of patients. Although, at this point there is no perfect cure in progress but patient well being should be supreme.
Sharmin:
I hope and pray that these companies continue to fine tune these procedures and bring them forward in the best interest of patients.
I'm looking forward to hearing Bluebird's results at the end of this year.
I hope that SK allows the cure that they are sitting on to get to the patients who need it.
Parin:
J.P. Morgan Healthcare Conference
http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyMTM4MDF8Q2hpbGRJRD02MDY1NDI=
if you unable to get attachement above click below link
http://investor.bluebirdbio.com/phoenix.zhtml?p=irol-eventDetails&c=251820&eventID=5213801
Sharmin:
Thank you for sharing Parin!
Navigation
[0] Message Index
[#] Next page
[*] Previous page
Go to full version